ArticleFrontiers in oncology2024

Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC.

Weijia Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.